Dr. Ali Dabestani, MD

Dr. Dabestani practices at Pet CT Pob - Positron Emission Tomography, Computed Tomography Professional Office Building - HOPD in Murrieta, California.

Dr. Dabestani's NPI, 1831213701, was assigned on March 18, 2007. Dr. Dabestani graduated from Shiraz University of Medical Sciences in 1974. Dr. Dabestani's California license number on file is A34447.

Dr. Dabestani's primary practice is Pet CT Pob - Positron Emission Tomography, Computed Tomography Professional Office Building - HOPD, at 28078 Baxter Road, Murrieta, CA 92563.

Dr. Dabestani's primary practice is Pet CT Pob - Positron Emission Tomography, Computed Tomography Professional Office Building - HOPD in Murrieta, California. Dr. Dabestani is also affiliated with Providence Mission Hospital. The medical group on file is SC Cardiology Medical Center. Dmand AI also links Dr. Dabestani to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dabestani practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Dabestani's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Dabestani is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Dabestani's licenses on file in 2 states: California and Iowa.

Dmand AI lists atrial fibrillation and flutter, cardiomyopathy, chronic hypertension, coronary artery disease, heart failure, high cholesterol, intermittent racing heartbeat (PSVT) and pulmonary heart disease among the conditions Dr. Dabestani treats.

CMS data shows 780 Medicare services from Dr. Dabestani across 10 procedure codes in 2024, for 457 Medicare patients. Medicare paid $36,772 for them.

CMS counts 457 Medicare patients who saw Dr. Dabestani in 2024. The largest group is 65 to 74, with 163 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dabestani's median patient age at 61, with 53% women.

In 2024, Dr. Dabestani wrote 980 Medicare Part D claims for 119 patients. 85% of them were for generic drugs. CMS names the drug for 760 of them, across 20 drugs with 11 or more claims each, at $58,271 in total drug cost. In 2023, CMS named 857 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Dabestani for performance year 2024, reported as part of a group. Dr. Dabestani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 19 papers to Dr. Dabestani. The most frequent topics are Echocardiography, Blood Flow Velocity and Aorta. Dr. Dabestani has published most often in Am J Cardiol. Dr. Dabestani's most frequent co-authors are Feizal Waffarn, MD, Gordon Arthur Glasgow, MD and Larry M. Noble, MD.

CMS Open Payments shows 17 general payments to Dr. Dabestani from 14 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 89% of the total. Boston Scientific Corporation paid the most, $150.

Dmand AI lists 2 awards for Dr. Dabestani, most recently CMS Stage 1 EHR in 2013.

Dr. Dabestani graduated from Shiraz University of Medical Sciences in 1974. Dr. Dabestani is a member of ACC.

Dr. Dabestani is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.